Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 21% ± 3% | |
| glutamatergic neuron | 5 studies | 39% ± 24% | |
| GABAergic neuron | 5 studies | 32% ± 19% | |
| epithelial cell | 4 studies | 25% ± 5% | |
| oligodendrocyte | 4 studies | 22% ± 3% | |
| interneuron | 4 studies | 29% ± 22% | |
| adipocyte | 3 studies | 23% ± 4% | |
| ciliated cell | 3 studies | 18% ± 2% | |
| astrocyte | 3 studies | 31% ± 1% | |
| oligodendrocyte precursor cell | 3 studies | 26% ± 2% | |
| fibroblast | 3 studies | 22% ± 5% | |
| macrophage | 3 studies | 29% ± 8% | |
| transit amplifying cell | 3 studies | 23% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 34% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2086.06 | 1445 / 1445 | 100% | 37.88 | 183 / 183 |
| liver | 100% | 6637.68 | 226 / 226 | 100% | 64.23 | 406 / 406 |
| ovary | 100% | 2583.01 | 180 / 180 | 100% | 22.22 | 430 / 430 |
| pancreas | 100% | 1793.14 | 328 / 328 | 100% | 32.90 | 178 / 178 |
| uterus | 100% | 2350.25 | 170 / 170 | 100% | 38.97 | 459 / 459 |
| thymus | 100% | 2780.82 | 653 / 653 | 100% | 35.38 | 604 / 605 |
| brain | 99% | 2474.39 | 2627 / 2642 | 100% | 32.29 | 705 / 705 |
| intestine | 100% | 2093.53 | 966 / 966 | 99% | 33.13 | 524 / 527 |
| prostate | 100% | 3408.97 | 245 / 245 | 99% | 49.21 | 499 / 502 |
| kidney | 100% | 2719.88 | 89 / 89 | 99% | 26.86 | 895 / 901 |
| stomach | 100% | 1982.92 | 359 / 359 | 99% | 30.84 | 284 / 286 |
| adrenal gland | 100% | 2442.08 | 258 / 258 | 99% | 28.95 | 228 / 230 |
| skin | 100% | 2386.47 | 1809 / 1809 | 99% | 30.68 | 467 / 472 |
| bladder | 100% | 2183.76 | 21 / 21 | 99% | 39.54 | 497 / 504 |
| breast | 100% | 2131.64 | 459 / 459 | 98% | 26.50 | 1098 / 1118 |
| lung | 100% | 2315.80 | 577 / 578 | 98% | 29.93 | 1131 / 1155 |
| adipose | 100% | 1980.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 35.87 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 49.52 | 29 / 29 |
| spleen | 100% | 3172.81 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 36.16 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 46.80 | 1 / 1 |
| muscle | 100% | 1700.75 | 802 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1520.35 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 1311.93 | 854 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 2263.54 | 918 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0018117 | Biological process | protein adenylylation |
| GO_0005694 | Cellular component | chromosome |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0070733 | Molecular function | AMPylase activity |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | SELENOO |
| Protein name | Protein adenylyltransferase SelO, mitochondrial (EC 2.7.7.-) (EC 2.7.7.108) (Selenoprotein O) (SelO) |
| Synonyms | SELO |
| Description | FUNCTION: Catalyzes the transfer of adenosine 5'-monophosphate (AMP) to Ser, Thr and Tyr residues of target proteins (AMPylation) . May be a redox-active mitochondrial selenoprotein which interacts with a redox target protein . . |
| Accessions | ENST00000380903.7 Q9BVL4 |